Trans sodium crocetinate: Phase II started

Diffusion began the Phase II portion of an open-label, U.S. Phase I/II trial of IV TSC plus radiation therapy and temozolomide following an independent safety monitoring committee review of safety data from the Phase I portion in 9 patients. The Phase II portion will evaluate TSC in about 50 newly diagnosed GBM patients. ...